A note from our Chair 

2021-22 has been pivotal for the AHSNs and the AHSN Network. While we are still supporting our health and care systems with the recovery from the pandemic, we have undertaken work to set out our vision and strategy and refine our processes to ensure we can meet our collective ambition to transform as many lives as possible through more rapid uptake of high value innovation in health and care.

This report reflects our national AHSN Network priorities and our impacts within these areas of work.

I’d like to thank all my colleagues from across the Network and our partners for their continued support this year. We know that team working is key to health system transformation and our achievements are only possible together.

Professor Gary Ford CBE, FMedSci
Chair of the AHSN Network and Chief Executive of Oxford AHSN

Image: cover of the AHSN Network impact report 21-22

 

 

 

 

 

 

Read the Impact Report PDF. You can see more impact stories on the pages below.

2021/22 impacts

Illustration. Text reads: More than 480,000 patients benefited from our national programmes and initiatives. 1,273 innovations in our national pipeline of innovation. £455 investment leveraged by companies supported by AHSNs.

  • 2025 NHS Innovation Accelerator Fellows  

    2025 NHS Innovation Accelerator Fellows  

    The NHS Innovation Accelerator (NIA) has revealed its 2025 cohort of Fellows. As the NIA celebrates a decade of helping to drive innovation in the NHS, this year’s cohort aligns with the Government’s three priorities: supporting the transition from analogue to digital, sickness to prevention and hospital to home.  The 28 new Fellows will benefit [...]

  • Launch of new “game changing” guide to tackle overprescribing and support Government’s shifts to prevention and community

    Launch of new “game changing” guide to tackle overprescribing and support Government’s shifts to prevention and community

    A new guide aimed at helping primary care organisations and integrated care boards understand and address problematic polypharmacy has been launched by the Health Innovation Network as part of its national Polypharmacy Programme. Developed in response to a clear need identified by primary care and prescribing colleagues, this essential resource provides practical, evidence-based strategies to [...]

  • Delivering the national cancer plan through innovation

    Delivering the national cancer plan through innovation

    Across England, innovation is improving cancer services and patient outcomes. Last week the government launched an open call for evidence to inform the National Cancer Plan.  Innovation has a critical role to play in supporting the delivery of any National Cancer Plan, and delivering on the government’s three shifts. In order to realise the significant [...]